Here is a list of the most common chemotherapy regimens used for non-Hodgkin's lymphoma.
The names in brackets are alternate names for the drug. Most often the Brand name. For example Doxorubicin is known by the brand name of Adriamycin which is why it often appears as the letter A and not D. (It also appears as the letter H since its longer name is Doxorubicin Hydrochloride)
| 2-CDP |
2- Chlorodeoxyadenosine |
| ABVD |
A = Doxorubicin (Adriamycin)
B = bleomycin
V = vinblastine
D = dacarbazine |
| BACOD |
B = Bleomycin
A = Doxorubicin (Adriamycin)
C = Cyclophosphamide
O = Vincristine
D = Dexamethasone |
| BEAM |
B = Carmustine (BCNU)
E = Etoposide (VP-16)
A = Cytarabine (ARA- C)
M = Melphalan |
| BMR |
B = Bendamustine
M = Mitoxantrone (Novantrone)
R = Rituxan
|
| BEACOP |
B = bleomycin
E = etoposide
A = doxorubicin (adriamycin)
C = cyclophosphamide O = vincristine (oncovin)
P = procarbazine
P = prednisone |
| BuMelTT |
Bu = Busulfan
Mel = Melphalan
TT = Thiotepa |
| CBV |
C = Cyclophosphamide
B = Carmustine (BCNU)
V = Etoposide (VP-16) |
| CEOP |
C = Cyclophosphamide
E = Epirubicin
O = Vincristine (oncovin)
P = Prednisolone |
| CEPP |
C = Cyclophosphamide
E = Etoposide (VP-16)
P = Procarbazine
P = Prednisone |
| CHOP |
C = Cyclophosphamide
H = Doxorubicin (adriamycin or Doxorubicin Hydrochloride
O = Vincristine (Oncovin)
p = prednisone |
| CHOP-R or R-CHOP |
CHOP as above, with Rituxan added |
| CMF |
C = Cyclophosphamide
M = Methotrexate
F = fluorouracil |
| CNOP |
C = Cyclophosphamide
M = Mitoxantrone (novantrone)
O = Vincristine (Oncovin)
P = Prednisone |
| COPADM |
C = Cyclophosphamide
O = Vincristine (Oncovin)
P = Prednisolone
A = Doxorubicin (adriamycin)
M = Methotrexate |
| COPP |
C = Cyclophosphamide
O = Vincristine (oncovin)
P = procarbazine
P = Prednisone |
| CVP |
C = Cyclophosphamide
V = Vincristine (oncovin)
P = Prednisone |
| CYVE |
CY = ARA-C (Cytarabine)
VE = Etoposide (VP-16 or Vespid) |
| DHAC |
D = Dexamethasone
H = Doxorubicin (adriamycin or Doxorubicin Hydrochloride)
A = ARA=C
C = Carboplatin |
| DHAP |
D = Dexamethasone (Decadron)
HA = High dose Ara-
C (Cytarabine)
P = Cisplatin (platinum) |
| DICE |
D = Dexamethasone
I = Ifosfamide
C = Cisplatin
E = Etoposide |
| DVP |
D = Daunorubicin
V = Vincristine
P = Prednisolone |
| EPOCH |
E = etoposide
P = prednisone
O = Oncovin (Vincristine)
C = Cyclophosphamide
H = Doxorubicin (adriamycin or Doxorubicin Hydrochloride) |
| ESHAP |
E = Etoposide
S = Methylprednisolone (solu medrol)
HA = High dose ARA-C (Cytarabine)
P = Cisplatin (Platinum) |
| FCM |
F = Fludarabine
C = Cyclophosphamide
M = Mitoxantrone |
| FND |
F = Fludarabine
N = Mitoxantrone (Novantrone)
D = Dexamethasone |
| FND+R |
Same as above but with Rituxan added |
| HyperCVAD |
HyperC = Hyperfractionated Cyclophosphamide,
V = Vincristine (Oncovin)
A = doxorubicin (Adriamycin)
D = dexamethasone |
| ICE |
I = Ifosfamide
C = Carboplatin
E = Etoposide |
| MACOP-B |
M = Methotrexate
A = Doxorubicin (Adriamycin)
C = Cyclophosphamide
O = Vincristine (Oncovin)
P = Prednisone
B = Bleomycin |
| McGrath protocol |
Too complicated to list here so download the document explaining it |
| MIME |
M = Mesna (alternative protocol uses Mitoguazon
I = Ifosfamide
M = Methotrexate
E = Etoposide |
| MINE |
M = Mesna
I = Ifosfamide
N = Mitoxantrone (Novantrone)
E = Etoposide (VP-16) |
| MOPP |
M = Mustine
O = Vincristine (oncovin)
P = Procarbazine
P = Prednisolone |
| PACE |
P = Cisplatin (Platinum)
A = Doxorubicin (Adriamycin)
C = Cyclophosphamide
E = Etoposide (VP-16) |
| PEP-C |
P = Prednisone
E = Etoposide
P = Procarbazine
C = Cyclophosphamide (low doses of each daily) |
| PROMACE CYTOBOM |
Promace part consists of
PRO = prednisone
M = methotrexate
A = Doxorubicin (Adriamycin)
C = Cyclophosphamide
E = Etoposide
Cytobom consists of
CYTA= Cytarabine
B = Beomycin
O = Vincristine (oncovin)
M = Methotrexate |
| RICE |
R = Rituxan
I = Ifosfamide
C = Carboplatin
E = Etoposide (VP-16) |
| VACOP-B |
V = Etoposide (VP-16
A = Doxorubicin (Adriamycin)
C = Cyclophosphamide
O = Vincristine (Oncovin)
P = Prednisone
B = Bleomycin |
| |
|
